Floatz logo

Aln-Pnp

Healthy Volunteers

Regeneron Pharmaceuticalsnucleic_acidPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

64 Active assets in the Healthy Volunteers cohort.

Asset / SponsorPhaseRating
Semaglutide
Novo Nordisk A/S
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
National Institute of Mental Health (NIMH)
Phase 4BB
DULAGLUTIDE
Novo Nordisk A/S
Phase 4BB
Alpha-1-Proteinase Inhibitor
Baxalta now part of Shire
Phase 4BB
Risperdal
University of Manchester
Phase 4BB

View all 50 →

Same molecule, other indications

Aln-Pnp is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
65 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
CC
Indicative ·
47 / 100
View asset →
inherited disease susceptibilityDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →